Stifel Nicolaus Starts Puma Biotechnology (PBYI) at Buy
Stifel Nicolaus initiates coverage on Puma Biotechnology (: PBYI) with a Buy. PT $19.00.
For an analyst ratings summary and ratings history on Puma Biotechnology click here. For more ratings news on Puma Biotechnology click here.
Shares of Puma Biotechnology closed at $13.90 yesterday.
For an analyst ratings summary and ratings history on Puma Biotechnology click here. For more ratings news on Puma Biotechnology click here.
Shares of Puma Biotechnology closed at $13.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- StoneX Starts Lennar (LEN) at Hold
- CIENA (CIEN) Reiterated at Buy by Stifel on Beat-and-Raise Quarter, Early Guidance
- BMO Capital Starts LunR Royalties Corp (LUNR:CN) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share